Visual and Electromyography Assessments in Response to Train-of-Four Stimulation of the Ulnar Nerve

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

August 18, 2020

Primary Completion Date

June 29, 2021

Study Completion Date

June 29, 2021

Conditions
Residual Neuromuscular Blockade
Interventions
DEVICE

TetraGraph

FDA approved neuromuscular transmission monitor capable of measuring the depth of neuromuscular block in anesthetized patients who received neuromuscular blocking agents. TetraGraph uses EMG to measure the muscle action potentials that are generated in response to electrical neurostimulation via skin electrodes.

Trial Locations (1)

32224

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER